Incidence and clinical features of cytomegalovirus infection diagnosed by cytomegalovirus pp65 antigenemia assay during high dose corticosteroid therapy for collagen vascular diseases

Clinical and Experimental Rheumatology

Volumn 24, Issue 6, 2006, Pages 649-655

  Yamashita, Masahiro ^a,b   Ishii, Tomonori ^b   Iwama, Noriyuki ^a,c   Takahashi, Hiroshi ^a  

^a Saka General Hospital   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Sendai Kosei Hospital   (Japan)

Author keywords

Clinical features; Collagen vascular diseases; Cytomegalovirus infection; Cytomegalovirus pp65 antigenemia; Risk factors

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIGEN PP65; GANCICLOVIR; LIVER ENZYME; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DEATH; DERMATOMYOSITIS; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INCIDENCE; JAPAN; LABORATORY TEST; MALE; MICROSCOPIC POLYANGIITIS; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE; VIRUS ENCEPHALITIS; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL ASSAY; COLLAGEN DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PREDNISOLONE; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES; VIRAL MATRIX PROTEINS;

EID: 33846417630     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. PETERSON PK, BALFOUR HH Jr, MARKER SC, FRYD DS, HOWARD RJ, SIMMON: Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 1980; 59: 283-300.
2. MACHER AM, REICHERT CM, STRAUS SE et al.: Death in the AIDS patient: role of cytomegalovirus. N Engl J Med 1983; 309: 1454.
3. GINZLER EM, DIAMOND HS, WEINER M et al.: A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-11.
4. SWAAK AJ, NOSSENT JC, BRONSVELD W et al.: Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 447-54.
5. FALK RJ, HOGAN S, CAREY TS, JENNETTE JC: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990; 113: 656-63.
6. TAKIZAWA H, SHIGA J, MOROI Y, MIYACHI S, NISHIWAKI M, MIYAMOTO T: Interstitial lung disease in dermatomyositis: clinico-pathological study. J Rheumatol 1987; 14: 102-7.
7. TAZELAAR HD, VIGGIANO RW, PICKRGILL J, COLBY TV: Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990; 141: 727-33.
8. AUSTIN HA 3rd, KLIPPEL JH, BALOW IF et al.: Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986; 314: 614-9.
9. NAWATA Y, KURASAWA K, TAKABAYASHI K et al.: Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J. Rheumatol 1999; 26: 1527-33.
10. NACHMAN PH, HOGAN SL, JENNETTE JC, FALK RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 33-9.
11. STAPLES PJ, GERDING DN, DECKER JL, GORDON RS Jr: Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17: 1-10.
12. PRYOR BD, BOLOGONA SG, KAHL LE: Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1475-82.
13. KADOYA A, OKADA J, IIKUNI Y, KONDO H: Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J. Rheumatol 1996; 23: 1186-8.
14. GODEAU B, MAINARDI JL, ROUDOT-THORAVAL F et al.: Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 1995; 54: 991-4.
15. KATZ A, EHRENFELD M, LIVNEH A et al.: Aspergillosis in systemic lupus erythematosus. Semin. Arthritis Rheum 1996; 26: 635-40.
16. MANZI S, KULLER LH, KUTZER J et al.: Herpes zoster in systemic lupus erythematosus. J. Rheumatol 1995; 22: 1254-8.
17. WEISS DJ, GREENFIELDG JW Jr, O'ROURKE KS, MCCUNE WJ: Systemic cytomegalovirus infection mimicking an exacerbation of Wegener's granulomatosis. J Rheumatol 1993; 20: 155-7.
18. ARINGER M, SMOLEN JS, GRANINGER WB: Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum 1998; 41: 414-20.
19. ZHANG C, SHEN K, JIANG Z, HE X: Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus. Chin Med J (Engl) 2001; 114: 1309-12.
20. SAKAMOTO O, ANDO M, YOSHIMATSU S, KOHROGI H, SUGA M, ANDO M: Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis. Intern Med 2002; 41: 151-5.
21. SHAHNAZ S, CHOKSI MT, TAN IJ: Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease. Mayo Clin Proc 2003; 78: 1412-5.
22. THE TH, van der BIJ W, van den BERG AP et al.: Cytomegalovirus antigenemia. Rev Infect Dis 1990; 12: S734-44.
23. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
24. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
25. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
26. BOHAN A, PETER JB: Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-7.
27. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al.: Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
28. AREND WP, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-34.
29. Criteria for diagnosis of Behçet's disease: International Study Group for Behȩt's Disease. Lancet 1990; 335: 1078-80.
30. HUNDER GG, BLOCH DA, MICHEL BA et al.: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
31. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
32. MILLS JA, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
33. EIZURU Y, MINEMATSU T, MINAMISHIMA Y et al.: Rapid diagnosis of cytomegalovirus infections by direct immunoperoxidase staining with human monoclonal antibody against an immediate early antigen. Microbiol Immunol 1991; 35: 1015-22.
34. van den BERG AP, van der BIJ W, van SON WJ et al.: Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consecutive patients. Transplantation 1989; 48: 991-5.
35. DOHERTY M, BRADFIELD JW: Polyarteritis nodosa associated with acute cytomegalovirus infection. Ann Rheum Dis 1981; 40: 419-21.
36. HASHIMOTO Y, NAWATA Y, KURASAWA K et al.: Investigation of EB virus and cytomegalovirus in rapidly progressive interstitial pneumonitis in polymyositis/dermatomyositis by in situ hybridization and polymerase chain reaction. Clin Immunol Immunopathol 1995; 77: 298-306.
37. McCORMICK JN, WOJTACHA D, EDOMOND E: Detection of cytomegalovirus antigens in phagocytosed serum complexes from a patient with rheumatoid arthritis, vasculitis, peripheral neuropathy, cutaneous ulceration, and digital gangrene. Ann Rheum Dis 1992; 51: 553-5.
38. SEKIZAWA I, NAWATA M, SETA N, YAMADA M, IIDA N, HASHIMOTO H: Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2002; 20: 559-64.
39. MARKIEWICZ M, SMITH EA, RUBINCHIK S, DONG JY, TROJANOWSKA M, LEROY EC: The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts. Clin Exp Rheumatol 2004; 22: S31-4.
40. MORI T, YOSHIMOTO R, MATSUDA T: Age distribution of seropositivity and titer of antibody against cytomegalovirus. Blood Programme (in Japanese) 1987; 10: 43-7.
41. MORI T, KAMEDA H, OGAWA H et al.: Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy. J Rheumatol 2004; 31: 1349-51.
42. ENRIGHT H, HAAKE R, WEISDORF D et al.: Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation 1993; 55: 1339-46.
43. AXELROD D, LEVENTHAL JR, GALLON LG, PARKER MA, KAUFMAN DB: Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients. Am J Transplant 2005; 5: 1423-9.